Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,587.95
(
0.08%
)
US TECH 100
23,441.79
(
0.18%
)
Dow Jones
46,521.37
(
0.04%
)
Brent Oil
107.51
(
-1.53%
)
Bitcoin
69,796.46
(
1.14%
)
News Focus
News Focus

Replies to post #7700 on PharmaCyte Biotech Inc (PMCB)

Replies to #7700 on PharmaCyte Biotech Inc (PMCB)
icon url

DITRstocks

05/02/13 8:37 AM

#7701 RE: DITRstocks #7700

Compensated Awareness Post View Disclaimer
The Celgene trial has garnered attention but there are other treatments under development that have not only garnered significant attention, but provide great valuation comparables for Nuvilex which strongly supports our valuation thesis.

$NVLX